Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Tarazosin
Drug ID BADD_D02117
Description Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension[FDA Label][A176831]. Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate[A176837].
Indications and Usage For the treatment of symptomatic BPH and mild to moderate hypertension.
Marketing Status Not Available
ATC Code Not Available
DrugBank ID DB01162
KEGG ID Not Available
MeSH ID Not Available
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 23155-737; 23155-736; 70518-3211; 23155-738; 67296-1264; 70518-3272; 70518-3193; 23155-735
Synonyms Not Available
Chemical Information
Molecular Formula Not Available
CAS Registry Number 63590-64-7
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Amblyopia06.02.01.001--Not Available
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Depression19.15.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dyspnoea22.02.01.004; 02.01.03.002--
Headache17.14.01.001--
Hypotension24.06.03.002--
Influenza22.07.02.001; 11.05.03.001--Not Available
Libido decreased21.03.02.005; 19.08.03.001--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Orthostatic hypotension24.06.03.004; 17.05.01.020--Not Available
Pain in extremity15.03.04.010--
Palpitations02.01.02.003--
Paraesthesia17.02.06.005--
Priapism21.03.01.005--Not Available
Pyrexia08.05.02.003--
Rhinitis22.07.03.006; 11.01.13.004--
Sinusitis22.07.03.007; 11.01.13.005--
Somnolence19.02.05.003; 17.02.04.006--
Syncope02.01.02.008; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Thrombocytopenia01.08.01.002--Not Available
Urinary tract infection20.08.02.001; 11.01.14.004--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
The 1th Page    1 2    Next   Last    Total 2 Pages